Mach7 Technologies Ltd
ASX:M7T
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.35
0.805
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Mach7 Technologies Ltd
Mach7 Technologies Ltd
Gross Profit
Mach7 Technologies Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Gross Profit
AU$28.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Gross Profit
AU$3.5m
|
CAGR 3-Years
204%
|
CAGR 5-Years
123%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Gross Profit
$24.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
18%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Gross Profit
AU$166m
|
CAGR 3-Years
35%
|
CAGR 5-Years
28%
|
CAGR 10-Years
28%
|
|
|
Medibio Ltd
ASX:MEB
|
Gross Profit
AU$963.6k
|
CAGR 3-Years
10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Medadvisor Ltd
ASX:MDR
|
Gross Profit
AU$74.2m
|
CAGR 3-Years
48%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Mach7 Technologies Ltd
Glance View
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.
See Also
What is Mach7 Technologies Ltd's Gross Profit?
Gross Profit
28.6m
AUD
Based on the financial report for Jun 30, 2024, Mach7 Technologies Ltd's Gross Profit amounts to 28.6m AUD.
What is Mach7 Technologies Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
30%
Over the last year, the Gross Profit growth was -3%. The average annual Gross Profit growth rates for Mach7 Technologies Ltd have been 16% over the past three years , 30% over the past five years .
You don't have any saved screeners yet
